Table 11.

Changes in lipid measures from day −14 to day 84

Variable	Day −14	Day 84	Within Group p-Value	Between Group p-Value
Cholesterol (mg/dL)
Placebo	202.2 (±54.0)	192.1 (±47.8)	0.066	0.787
AF1	198.1 (±59.5)	187.2 (±35.8)	0.153
AF2	197.0 (±43.3)	190.9 (±39.3)	0.086
AF1 + AF2	197.5 (±50.9)	189.2 (±37.4)	0.036
Triglycerides (mg/dL)
Placebo	156.0 (±126.7)	143.4 (±101.7)	0.473	0.465
AF1	112.7 (±60.9)	118.2 (±88.1)	0.626
AF2	144.4 (±112.1)	129.7 (±80.0)	0.153
AF1 + AF2	129.9 (±92.9)	124.4 (±83.3)	0.470
HDL (mg/dL)
Placebo	55.1 (±17.4)	53.3 (±15.9)	0.209	0.294
AF1	56.5 (±18.9)	55.5 (±19.3)	0.258
AF2	52.2 (±16.1)	52.8 (±15.7)	0.577
AF1 + AF2	54.2 (±17.4)	54.0 (±17.3)	0.853
LDL (mg/dL)
Placebo	115.1 (±37.4)	110.1 (±38.1)	0.217	0.550
AF1	119.1 (±54.9)	108.0 (±33.4)	0.154
AF2	119.7 (±32.8)	116.1 (±29.0)	0.254
AF1 + AF2	119.4 (±43.9)	112.4 (±31.1)	0.072

Values Presented as Mean ± Standard Deviation

Values determined to be significant (p = <0.05) indicated